1. Home
  2. NE vs GKOS Comparison

NE vs GKOS Comparison

Compare NE & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Noble Corporation plc A

NE

Noble Corporation plc A

HOLD

Current Price

$40.54

Market Cap

8.0B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$169.55

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NE
GKOS
Founded
1985
1998
Country
United States
United States
Employees
4500
N/A
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
NE
GKOS
Price
$40.54
$169.55
Analyst Decision
Buy
Strong Buy
Analyst Count
7
12
Target Price
$46.00
$126.92
AVG Volume (30 Days)
1.7M
843.3K
Earning Date
04-26-2026
04-29-2026
Dividend Yield
3.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
N/A
$23.32
Revenue Next Year
$9.18
$27.43
P/E Ratio
$32.79
N/A
Revenue Growth
N/A
32.33
52 Week Low
$26.20
$73.16
52 Week High
$54.98
$184.00

Technical Indicators

Market Signals
Indicator
NE
GKOS
Relative Strength Index (RSI) N/A 72.97
Support Level N/A $98.22
Resistance Level N/A N/A
Average True Range (ATR) 0.00 7.09
MACD 0.00 0.97
Stochastic Oscillator 0.00 64.00

Price Performance

Historical Comparison
NE
GKOS

About NE Noble Corporation plc A

Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and on deploying its drilling rigs in oil and gas basins around the world. The mobile offshore drilling units comprising the offshore rig fleet operate in international markets for contract drilling services and are often redeployed to different regions due to changing customer demand, which consists mainly of large, integrated, independent, and government-owned or controlled oil and gas companies throughout the world.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: